Publications

The GW Regulatory Studies Center scholars regularly conduct applied research to understand regulatory policy and practice from a public interest perspective. Our content often takes the form of public interest comments, formal testimony, working papers, policy insights, and short commentaries analyzing the most pressing issues in regulatory policy. View the rest of our material by the different types of publications listed on this page or our research areas.

Browse All Publications

 


What We Publish

Illustration of speech bubbles, indicating comments

Public Comments & Testimonies

Scholarly analysis of the potential effects of particular rulemakings from federal agencies, and advice to Congress on how to improve the rulemaking process.

 

Image of magnifying glass over speech bubble

Commentaries & Insights

Short-form publications intended for all audiences which provide easy to access analysis of regulatory policy.

Image of an open book

Books & Reports

Formal publications, often completed with other leading organizations and individuals, providing a thorough understanding of regulations and the rulemaking process.

Image of document with cogs

Newsletters

The weekly Regulation Digest contains everything you need to know about regulatory policy today, and our monthly Center Update gives you all of the latest from our team.

 

For accessible charts and supporting data that you can use in your own publications or presentations, visit the Reg Stats page.

 


Latest Publications 

The Trend and Fluctuations in News Attention to Regulation

Regulation has been drawing increasing media coverage in recent years alongside important regulatory developments and historical events.

Policymaking through Adjudication: DEA’s Red Flags

DEA's red flags policy has made some pharmacies reluctant to fill prescriptions for buprenorphine, a drug that can help tackle the opioid crisis.

A Vast and Discretionary Regime

Federal agencies have significant discretion to remove or alter regulatory barriers to methadone treatment.

Court Decision Extends the Period for Issuing Midnight Rules

A court decision found that agencies cannot withdraw a final rule that has appeared in the Federal Register for public inspection without notice and comment.

Factors Contributing to the Infant Formula Shortage

To reduce the risk of infant formula shortages in the future, the government should eliminate the barriers to entry under its control.

Nostalgia for Agency Expertise

Calls for more deference to agency expertise derive from an unrealistic view of executive policymaking.

Methadone Treatment for Opioid Use Disorder

This report on the proceedings of a National Academies of Sciences workshop features research and commentary from Bridget Dooling and Laura Stanley.

Is Chevron Deference Still Alive?

Three takeaways follow from the Supreme Court’s recent opinions ignoring Chevron v. NRDC.

Biden's Spring 2022 Unified Agenda

The Spring 2022 Unified Agenda suggests the Biden administration is focusing on priorities related to the environment, health, immigration, and education.

Factors Contributing to the Infant Formula Shortage

The Federal Trade Commission (FTC) has solicited public comments on the factors that may have contributed to the recent infant formula shortage.